Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SANTHERA-PHARMACEUTICALS--195471/news/Santhera-meldet-positive-Studiendaten-fur-Vamorolone-und-plant-FDA-Zulassung-35482808/?utm_source=whatsapp&utm_medium=social&utm_campaign=share